Clinical Trial Update: A Phase IB/II Clinical Study of SHR-9839 for Injection Combined With Other Anti-tumor Therapies in Patients With Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update notes a Phase Ib/II study to evaluate SHR-9839 in combination with other anti-tumor therapies for patients with advanced solid tumors…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• SHR-9839

Snippet

Sponsor: Shanghai Hengrui Pharmaceutical Co., Ltd. | Conditions: Advanced Solid Tumors | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING